Publication

LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men

Cell Reports Medicine 3(4):100582, 2022

Hageman CA, Jensen MS, Holm S, Gasbjerg LS, Byberg S, Skov-Jeppesen K, Hartmann B, Holst JJ, Dela F, Vilsbøll T, Christensen MB, Holst B, Knop FK

Subjects

Human Target Mouse Compound Method/Endpoint Diabetes Species Clinical trial Obesity Ghrelin receptor LEAP-2 Real-time food intake/activity analysis

Share this page

Resource Library

Related resources

GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice

Novel insight into the distribution of L-cells in the rat intestinal tract

GIP affects hepatic fat and brown adipose tissue thermogenesis, but not white adipose tissue transcriptome in T1D

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650